LACOSAMIDE

NDC 51991-351 · Breckenridge Pharmaceutical, Inc.

Generic nameLACOSAMIDE

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)LACOSAMIDE

Strength200 mg/1

Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]

DEA scheduleCV

Marketing categoryANDA

Packages

51991-351-05 — 500 TABLET, FILM COATED in 1 BOTTLE (51991-351-05)

51991-351-06 — 60 TABLET, FILM COATED in 1 BOTTLE (51991-351-06)

FDA lists these products with the same active ingredient.

50228-193 — LACOSAMIDE, 50228-194 — LACOSAMIDE, 50228-195 — LACOSAMIDE, 51407-721 — LACOSAMIDE, 51407-722 — LACOSAMIDE, 51407-723 — LACOSAMIDE, 51407-724 — LACOSAMIDE, 51991-348 — LACOSAMIDE, 51991-349 — LACOSAMIDE, 51991-350 — LACOSAMIDE, 53746-923 — Lacosamide, 53746-924 — Lacosamide, 53746-925 — Lacosamide, 53746-926 — Lacosamide, 58118-8812 — LACOSAMIDE, 58118-8813 — LACOSAMIDE, 58118-8814 — LACOSAMIDE, 58118-8815 — LACOSAMIDE, 59651-016 — Lacosamide, 60505-6235 — lacosamide, +141 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.